Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - anastrozole, quantity: 1 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; sodium starch glycollate type a; hypromellose; titanium dioxide; macrogol 300 - early breast cancer: . adjuvant treatment of early breast cancer in postmenopausal women with oestrogen/progesterone-receptor-positive disease. . advanced breast cancer :. first line treatment of advanced breast cancer in postmenopausal women with oestrogen/progesterone-receptor-positive disease. . treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. patients with oestrogen-receptor-negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to anastrozole.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - anastrozole -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - anastrozole, quantity: 1 mg - tablet, film coated - excipient ingredients: hypromellose; sodium starch glycollate; magnesium stearate; lactose; titanium dioxide; macrogol 8000; triacetin; polydextrose - advanced breast cancer: . first line treatment of advanced breast cancer in postmenopausal women with oestrogen/progesterone-receptor-positive disease.. treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. patients with oestrogen-receptor-negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to anastrozole.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - felodipine; ramipril - modified-release tablet - 5mg ; 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - felodipine; ramipril - modified-release tablet - 2.5mg ; 2.5mg

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - anastrozole -

United States - English - NLM (National Library of Medicine)

viatrexx bio incorporated - bos taurus adrenal gland (unii: m2776swb29) (bos taurus adrenal gland - unii:m2776swb29), sus scrofa adrenal gland (unii: 398iyq16yv) (sus scrofa adrenal gland - unii:398iyq16yv), aldosterone (unii: 4964p6t9rb) (aldosterone - unii:4964p6t9rb), androsterone (unii: c24w7j5d5r) (androsterone - unii:c24w7j5d5r), adenosine cyclic phosphate (unii: e0399ozs9n) (adenosine cyclic phosphate - unii:e0399ozs9n), cholesterol (unii: 97c5t2uq7j) (cholesterol - unii:97c5t2uq7j), prasterone (unii: 459ag36t1b) (prasterone - - viatrexx-male plus  a sterile, injectable, biodegradable, clear isotonic liquid that is injected into the various layers of the skin, muscles, ligaments, joints, other body tissues or added to an iv, either as a push or into the bag. this product should not be used in patients with a known hypersensitivity to any ingredient found in the formula, porcine products, isotonic saline or benzyl alcohol, or patients with a history of severe allergies. as with all injections, epinephrine injection (1:1,000) must be immediately available should an acute anaphylactoid reaction occur due to any component of the injection. this product contains 1% benzyl alcohol. benzyl alcohol has been reported to be associated with a fatal "gasping syndrome" in premature infants. due to the benzyl alcohol content, this product should not be given to a pregnant woman. this product should not be used in patients with a known hypersensitivity to any ingredient in this formula, porcine products, isotonic saline or benzyl alcohol, or patien

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - felodipine ramipril - tablet prolonged release - 5mg/5mg milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - felodipine; ramipril - prolonged-release tablet - 5 mg/5 milligram(s) - ace inhibitors and calcium channel blockers; ramipril and felodipine

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - felodipine; ramipril - prolonged-release tablet - 2.5 mg/2.5 milligram(s) - ace inhibitors and calcium channel blockers; ramipril and felodipine